Why the study?
Angiosarcoma is a rare but very aggressive tumor, with approximately 8% arising in the breast.
Dynamic contrast-enhanced MRI is a helpful imaging tool for diagnosing and evaluating primary breast angiosarcoma.
Answers are grounded in this paper and cite their sources.
Variable DCE-MRI features may complicate diagnosis of primary breast angiosarcoma; leaves open standardized criteria for rare tumors.
Angiosarcoma is a rare but very aggressive tumor. It occurs in all organs of the body, and approximately 8% of all angiosarcomas arise in the breast. We reported 2 cases of primary breast angiosarcomas in young women. The 2 patients showed similar clinical features, but were quite different in dynamic contrast-enhanced MR imaging. The 2 patients were treated with mastectomy and axillary sentinel lymph node dissection and confirmed by post-operative pathological test. We suggested that dynamic contrast-enhanced MR imaging was the most helpful imaging tool in the diagnosis and pre-operative evaluation of the breast angiosarcoma.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: